Showing results (21-30 of 7,708) with videos related to

Sort By:
Pageof 771
Asia-Pacific Journal of Clinical Oncology|February 21, 2020
Recognition and management of the gastrointestinal and hepatic immune-related adverse eventsBei Tan, Yue Li, Yan Xu, et al.
Thoracic Cancer|September 19, 2017
Clinical characteristics of patients with lung cancer and idiopathic pulmonary fibrosis in ChinaYan Xu, Wei Zhong, Li Zhang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|July 10, 2025
[Lung Adenocarcinoma with EGFR Exon 20 H773_V774delinsLM Mutation Sensitive to Furmonertinib: A Case Report]Rongzhen Li, Yan Xu, Xiaoxing Gao, et al.
Cancer Medicine|August 16, 2018
Efficacy of icotinib in advanced lung squamous cell carcinomaShuai Liang, Yan Xu, Fenlai Tan, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 27, 2016
[Clinical Features of Intradural Extramedullary Spinal Cord Metastases in Primary Lung Cancer]Yan Xu, Wei Zhong, Jing Zhao, et al.
Oncotarget|November 22, 2017
Harness the synergy between targeted therapy and immunotherapy: what have we learned and where are we headed?Xiaoyan Liu, Qing Zhou, Yan Xu, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|April 14, 2025
Clinical management of checkpoint inhibitor pneumonitis: Focus, challenges, and future directionsYan Xu, Ruxuan Chen, Ruili Pan, et al.
Thoracic Cancer|August 15, 2015
The Prevalence and clinical characteristics of primary Sjogren's syndrome patients with lung cancer: An analysis of ten cases in China and literature reviewYan Xu, Yunyun Fei, Wei Zhong, et al.
Oncotarget|November 22, 2017
Prognostic significance of circulating tumor cells in non-small cell lung cancer patients undergoing chemotherapyBing Tong, Yan Xu, Jing Zhao, et al.
Thoracic Cancer|March 28, 2018
Prognostic role of circulating tumor cells in patients with EGFR-mutated or ALK-rearranged non-small cell lung cancerBing Tong, Yan Xu, Jing Zhao, et al.
Pageof 771